KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Long-Term Debt Repayments (2024)

Inovio Pharmaceuticals (INO) has disclosed Long-Term Debt Repayments for 1 consecutive years, with $16.4 million as the latest value for Q1 2024.

  • Quarterly Long-Term Debt Repayments changed N/A to $16.4 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $16.4 million through Dec 2024, changed N/A year-over-year, with the annual reading at $16.4 million for FY2024, N/A changed from the prior year.
  • Long-Term Debt Repayments hit $16.4 million in Q1 2024 for Inovio Pharmaceuticals.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $16.4 million in Q1 2024 to a low of $16.4 million in Q1 2024.